What Is an ACOUSTIC Neuroma?

An ACOUSTIC neuroma (vestibular schwannoma) is a benign tumor that grows on the eighth cranial nerve, which carries both auditory and balance signals from the inner ear to the brainstem. These slow-growing tumors are distinct from glial tumors such as astrocytoma, which arise from supportive cells in the brain rather than from the nerve sheath. Because of their location, acoustic neuromas can disrupt hearing and balance even before treatment.

Gamma Knife and Hearing Preservation

Gamma knife radiosurgery delivers a single, highly focused dose of radiation to the tumor while sparing nearby structures. The goal is to stop tumor growth and reduce the need for open surgery. However, hearing preservation remains a challenge. Many patients with useful hearing before treatment experience a decline in hearing over the months and years after radiosurgery.

Patterns of Hearing Loss After Radiosurgery

The hearing loss associated with gamma knife treatment is typically sensorineural, meaning it originates in the cochlea, the auditory nerve, or the brainstem pathways rather than in the outer or middle ear. High-frequency thresholds often deteriorate first, and word recognition scores may fall even when pure-tone averages remain stable. Some patients notice sudden drops in hearing; others experience a gradual decline over several years. Fewer than half of patients with initially good hearing maintain their pre-treatment hearing level over the long term, although the rate of hearing deterioration varies with tumor size, radiation dose to the cochlea, and the patient's baseline auditory reserve.

The Role of MRI in Monitoring

Contrast-enhanced MRI is the standard imaging method for following acoustic neuromas after gamma knife treatment. Serial MRI scans are used to measure tumor dimensions and to distinguish radiation-related changes from true tumor progression. Growth of the tumor may be seen as an increase in enhancing volume, while central necrosis or swelling can occur without actual tumor regrowth. Because not all tumors respond identically, MRI findings must always be correlated with hearing tests and clinical symptoms. MRI also helps rule out other intracranial tumors, including astrocytoma and other glial neoplasms, when a patient with a known acoustic neuroma presents with new neurological signs.

Auditory Brainstem Response Testing

ABR, also known as auditory brainstem response audiometry, measures electrical activity from the cochlea and auditory nerve to the brainstem in response to sound. Before treatment, ABR can help confirm the retrocochlear site of a lesion. After gamma knife radiosurgery, repeated ABR testing can detect subtle changes in neural conduction that may precede a decline in pure-tone thresholds. Prolongation of the interwave intervals or a fall in wave V amplitude can indicate progressive injury to the auditory nerve, even when the patient is not yet aware of a hearing problem.

Vertigo and Balance Symptoms

Vertigo is a common complaint among patients with acoustic neuroma, both before and after gamma knife treatment. The tumor itself may compress the vestibular nerve or disturb the blood supply to the inner ear, producing rotational vertigo, disequilibrium, or persistent unsteadiness. Radiation can also cause temporary swelling of the tumor or the surrounding brainstem, which may worsen or trigger vertigo in the first few months after treatment. Most patients experience some degree of vestibular compensation over time, but elderly patients and those with pre-existing vestibular loss may recover more slowly. Vestibular rehabilitation exercises can be helpful in reducing imbalance, although repeated or disabling vertigo should always be investigated with MRI and a neurological examination.

Other Tumors and Differential Diagnosis

Although acoustic neuromas are the most common tumors of the cerebellopontine angle, other lesions can mimic them on imaging and clinical presentation. Meningiomas, epidermoid cysts, facial nerve schwannomas, and even brainstem gliomas such as astrocytoma may produce similar symptoms of hearing loss, tinnitus, facial weakness, or vertigo. The distinction between these tumors is important because the expected response to radiosurgery and the risk to the auditory system differ considerably.

Monitoring and Follow-Up

Standard follow-up after gamma knife treatment for acoustic neuroma includes serial contrast-enhanced MRI and audiometric evaluation. Most centers recommend an MRI at six to twelve months after treatment, followed by yearly scans if the tumor is stable. Audiometry should include pure-tone thresholds, word recognition scores, and acoustic reflex testing. ABR may be added when there is a discrepancy between the imaging findings and the patient's hearing complaints. Sensorineural hearing loss that develops long after radiosurgery is not always caused by tumor progression. For this reason, sudden deterioration of hearing should prompt repeat imaging to exclude cystic changes, intratumoral hemorrhage, or hydrocephalus.

Summary

Gamma knife radiosurgery is an effective method of controlling acoustic neuromas, but it carries a real risk of progressive sensorineural hearing loss. Patients who present with good hearing and small tumors have the best chance of preserving auditory function. Objective tests, including ABR and MRI, help clinicians identify early signs of nerve injury and distinguish tumor growth from treatment-related change. Vertigo and imbalance require a separate evaluation and often respond to vestibular rehabilitation. Anyone considering treatment for an acoustic neuroma should discuss the risks and benefits of radiosurgery, surgical resection, and observational follow-up with a specialist familiar with these tumors.